Biology and pathology of the mitochondrion

Ultrastructural Pathology

Volumn 22, Issue 5, 1998, Pages 357-367

  Lloreta Trull, Josep ^a,b   Serrano, Sergi ^b  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Mitochondrion; Pathology; Ultrastructure

Indexed keywords

CELL ULTRASTRUCTURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HISTOPATHOLOGY; HUMAN; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; SYMBIOSIS;

EID: 0032434125     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.3109/01913129809103357     Document Type: Review

References (80)

1. Ramón y Cajal S, Tello y Muñoz JF. Elementos de Histologia Normal y de Técnica Micrográfica. Madrid: Tipografia Artistica; 1931.
2. Fawcett DW. The Cell. Philadelphia: Saunders; 1981.
3. Palade GE. An electron microscope study of the mitochondrial structure. J Histochem Cytochem. 1953;1:188-211.
4. Ghadially FN. Ultrastructural Pathology of the Cell and Matrix. Boston: Butterworth-Heinemann; 1997.
5. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Molecular Biology of the Cell. New York: Garland; 1994.
6. Cann RL, Stoneking M, Wilson AC. Mitochondrial DMA and human evolution. Nature. 1987;325:31-36.
7. Cooper JM, Clark JB. The structural organization of the mitochondrial respiratory chain. In: Schapira AHV, DiMauro S, eds. Mitochondrial Disorders in Neurology. Oxford, UK: Butterworth-Heinemann; 1994:1-30.
8. Murphy AN, Bredesen DE, Cortopassi G, Wang E, Fiskum G. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc Natl Acad Sci USA. 1996;93:9893-9898.
9. Park JR, Hockenbery DM. Bcl-2, a novel regulator of apoptosis. J Cell Biochem. 1996;60:12-17.
10. Petit PX, Susin SA, Zamzami N, Mignotte B, Kroemer G. Mitochondria and programmed cell death: back to the future. FEBS Lett. 1996;396:7-13.
11. Riparbelli MG, Callaini G, Tripodi SA, Cintorino M, Tosi P, Dallai R. Localization of the Bcl-2 protein to the outer mitochondrial membrane by electron microscopy. Exp Cell Res. 1995;221:363-369.
12. Ross DW. Mitochondrial Eve. Arch Pathol Lab Med. 1991;115:544.
13. Sherratt HSA. Mitochondria: structure and function. Rev Neurol (Paris). 1991;147:417-430.
14. Skulachev VP. Why are mitochondria involved in apoptosis? Permeability transition pores and apoptosis as selective mechanisms to eliminate superoxide-producing mitochondria and cell. FEBS Lett. 1996;397:7-10.
15. Susin SA, Zamzami N, Castedo M, et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med. 1996;184:1331-1341.
16. Sparaco M, Bonilla E, DiMauro S, Powers JM. Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol. 1993;52:1-10.
17. Greene WB, Balentine JD, Hennigar GR. Selective mitochondrial degeneration in renal tubules following hyperbaric oxygen exposure. Am J Pathol. 1979;96:737-752.
18. Engel AG. Electron microscopic observations in thyrotoxic and corticosteroid-induced myopathies. Mayo Clin Proc. 1966;41:785-796.
19. Lloreta J, Roquer J, Corominas JM, Serrano S. Hyperthyroid myopathy with mitochondrial paracrystalline rectangular inclusions. Ultrastruct Pathol. 1996;20:61-65.
20. Lloreta J, Orozco M, Gea J, Corominas JM, Serrano S. Selective diaphragmatic mitochondrial abnormalities in a patient with marked air flow obstruction. Ultrastruct Pathol. 1996;20:67-71.
21. Shoffner JM, Wallace DC. Recent advances in mitochondrial genetics. In: Schapira AHV, DiMauro S, eds. Mitochondrial Disorders in Neurology. Oxford, UK: Butterworth-Heinemann; 1994:199-226.
22. Ankel-Simons F, Cummins JM. Misconceptions about mitochondria and mammalian fertilization: implications for theories on human evolution. Proc Natl Acad Sci USA. 1996;93:13859-13863.
23. Bloomer JR. Porphyrin metabolism. In: Arias I, Popper H, Schachter D, Shafritz DA, eds. The Liver: Biology and Pathobiology. New York. Raven; 1982:333-345.
24. Cahard D, Canat X, Carayon P, Roque C, Casellas P, Le Fur G. Subcellular localization of peripheral benzodiazepine receptors on human leukocytes. Lab Invest. 1994;70:23-28.
25. Drugan RC. Are the non-mitochondrial peripheral benzodiazepine receptors on leukocytes a novel intermediary of brain, behavior, and immunity? Lab Invest. 1994;70:1-5.
26. Ankarcrona M, Dypbukt JM, Orrenius S, Nicotera P. Calcineurin and mitochondrial function in glutamate-induced neuronal cell death. FEBS Lett. 1996;394:321-324.
27. Marchetti P, Hirsch T, Zamzami N, et al. Mitochondrial permeability transition triggers lymphocyte apoptosis. J Immunol. 1996;157:4830-4836.
28. Saetersdal TS, Myklebust R, Berg Justesen NP, Engedal H, Olsen WC. Calcium containing particles in mitochondria of heart muscle cells as shown by cryo-ultramicrotomy and X-ray microanalysis. Cell Tissue Res. 1977;182:17-31.
29. Khandoudi N, James F, Feuvray D. Influence of intracellular pH on the mitochondrial calcium during ischaemia of the isolated rat heart. Histochem J. 1989;21:99-106.
30. Rozman C, Woessner S, Feliu E, Lafuente R, Berga L. Ultraestrauctura Celular en Hematologia. Barcelona: Salvat Editores; 1990.
31. Angquist KA, Sjöström M. Intermittent claudication and muscle fiber fine structure: morphometric data on mitochondrial volumes. Ultrastruct Pathol. 1980;1:461-470.
32. Schmiedl A, Schnabel PA, Mall G, et al. The surface to volume ratio of mitochondria, a suitable parameter for evaluating mitochondrial swelling: correlations during the course of myocardial global ischaemia. Virchows Archiv A Pathol Anat. 1990;416:305-315.
33. Tashiro A, Masuda T, Segawa I. Morphometric comparison of mitochondria and myofibrils or cardiomyocytes between hypertrophic and dilated cardiomyopathies. Virchows Archiv A Pathol Anat. 1990;416:473-478.
34. Wu PC, Lai CL, Liddel RHA. Quantitative morphology of mitochondria in hepatocellular carcinoma and chronic liver disease. Arch Pathol Lab Med. 1984;108:914-916.
35. Harb JM, Copeland DE. Helical form cristae in the mitochondria of the pseudobranch of Cyprinodon variegatus adapted to conditions of constant light and darkness. J Cell Biol. 1974;62:886-889.
36. Matias C, Nunes JF, Sobrinho LG, Soares J. Giant mitochondria and intramitochondrial inclusions in benign thyroid lesions. Ultrastruct Pathol. 1991;15:221-229.
37. Phillips MJ, Poucell S, Patterson J, Valencia P. The Liver: An Atlas and Text of Ultrastructural Pathology. New York: Raven; 1987.
38. Robertson NJ, Kendall CH. Liver giant mitochondria revisited. J Clin Pathol. 1992;45:412-415.
39. Shapiro SH, Klavins JV. Concentric membranous bodies and giant mitochondria in hepatocytes from a patient with AIDS. Ultrastruct Pathol. 1993;17:557-563.
40. Engel AG, Banker BQ. Ultrastructural changes in diseased muscle. In: Myology. Engel AG, Franzini-Armstrong C, eds. Myology. New York: McGraw Hill; 1994;889-1017.
41. Erlandson RA, Tandler B. Lieberman PH, Higinbotham NL. Ultrastructure of human chordoma. Cancer Res. 1968;28:2115-2125.
42. Coleman M, Henderson DW, Mukherjee TM. The ultrastructural pathology of malignant pleural mesothelioma. Pathol Annu. 1989;24(pt 1):303-353.
43. Armiger LC, Herdson PB, Gavin JB. Mitochondrial changes in dog myocardium induced by lowered pH in vitro. Lab Invest. 1975;32:223-226.
44. Trump BF, Valigorsky, JM, Jones RT, Mergner WJ, Garcia JH, Cowley RA. The application of electron microscopy and cellular biochemistry to the autopsy: observations on cellular changes in human stock. Hum Pathol. 1975;6:499-516.
45. Rowland LP. Mitochondrial encephalomyopathies: lumping, splitting and melding. In: Schapira AHV, DiMauro S, eds. Mitochondrial Disorders in Neurology. Oxford, UK: Butterworth-Heinemann; 1994:116-129.
46. Morgan-Hughes JA, Cooper JM, Schapira AHV, et al. The molecular pathology of human respiratory chain defects. Rev Neurol (Paris) 1991;147:450-454.
47. Schon EA. Mitochondrial DNA and the genetics of mitochondrial disease. In: Schapira AHV, DiMauro S, et al. Mitochondrial Disorders in Neurology. Oxford, UK: Butterworth-Heinemann; 1994:31-48.
48. Degoul F, Diry M, Pou-Serradell A, Lloreta J, Marsac C, Myo-leukoencephalopathy in twins: study of 3243-myopathy, encephalopathy, lactic acidosis, and stroke-like episodes mitochondrial DNA mutation. Ann Neurol. 1994;35:365-370.
49. Hammans SR, Morgan-Hughes JA. Mitochondrial myopathies: clinical features, investigation, treatment and genetic counseling. In: Schapira AHV, DiMauro S, eds. Mitochondrial Disorders in Neurology. Oxford, UK: Butterworth-Heinemann; 1994:49-74.
50. DiMauro S, Bonilla E, Zeviani M, Nakagawa M, DeVivo DC. Mitochondrial myopathies. Ann Neurol. 1985;17:521-538.
51. Holt U, Harding AE, Cooper JM, et al. Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol. 1989; 26:699-708.
52. Semino-Mora C, León-Monzón M, Dalakas MC. Mitochondrial and cellular toxicity induced by fialuridine in human muscle in vitro. Lab Invest. 1997;76:487-495.
53. D'Amati G, Lewis W. Zidovudine causes early increases in mitochondrial ribonucleic acid abundance and induces ultrastructural changes in cultured mouse muscle cells. Lab Invest. 1994;71:879-884.
54. Lamperth L, Dalakas MC, Dagani F, Anderson J, Ferrari R. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab Invest. 1991;65:742-751.
55. Lewis W, Papoian T, Gonzalez B, et al. Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts. Lab Invest. 1991;65:228-236.
56. Lindal S, Lund I, Tobergsen T, et al. Mitochondrial diseases and myopathies: a series of muscle biopsy specimens with ultrastructural changes in the mitochondria. Ultrastruct Pathol. 1992;16:263-275.
57. Howl JD, Publicover SJ. Lipidic mitochondrial inclusions in experimentally induced in vitro myopathy of mouse diaphragm. Comp Biochem Physiol. 1990;95:833-837.
58. Mackay B, Ordóñez NG, Khoursand J, Bennington JL. The ultrastructure and immunocytochemistry of renal cell carcinoma. Ultrastruct Pathol. 1987;11:483-502.
59. Erlandson RA, Shek TWH, Reuter VE. Diagnostic significance of mitochondria in four types of renal epithelial neoplasms: an ultrastructural study of 60 tumors. Ultrastruct Pathol. 1997;21:409-417.
60. Mandel EM, Fishman P, Kissin E, Har-Zaav L, Djaldetti M. Intramitochondrial crystalline inclusions in the liver of a patient with hyperthyroidism. Acta Hepatogastroenterol (Stuttg). 1976;23:182-186.
61. Brawn PN, Mackay B. Intracristal crystalline inclusions in mitochondria of a neuroblastoma. Ultrastruct Pathol. 1980;1:495-497.
62. Sahgal V, Subramani V, Hughes R, Shah A, Singh H. On the pathogenesis of mitochondrial myopathies: an experimental study. Acta Neuropathol (Berl). 1979;46:177-183.
63. Hammersen F, Gidlof A, Larsson J, Lewis DH. The occurrence of paracrystalline mitochondrial inclusions in normal human skeletal muscle. Acta Neuropathol (Berl). 1980;49:35-41.
64. Ohira Y, Kanzaki M, Chen CS. Intramitochondrial inclusions caused by depletion of creatine in rat skeletal muscles. Jpn J Physiol. 1988;38:159-166.
65. Gunning WT, Haselhuhn GD, Phillips ER, Selman SH. An adrenocortical oncocytoma with unusual mitochondrial inclusions and cytoplasmic crystals. In: Bailey GW, Garratt-Reed AJ, eds: Proceedings of the Fifty-second Annual Meeting of the Microscopy Society of America. San Francisco: San Francisco Press; 1994;250-251.
66. Ghadially FN. Ultrastructural Pathology of the Cell and Matrix. London: Butterworth; 1988.
67. Eble JN, Hull MT. Morphologic features of renal oncocytoma: a light and electron microscopic study. Hum Pathol. 1984;15:1054-1061.
68. Brandwein MS, Huvos AG. Oncocytic tumors of major salivary glands: a study of 68 cases with follow-up of 44 cases. Am J Surg Pathol. 1991;15:514-528.
69. Kovacs K, Horvath E. Pituitary "chromophobe" adenoma composed of oncocytes: a light and electron microscopic study. Arch Pathol. 1973;95:235-239.
70. Carcangiu ML, Bianchi S, Savino D, Voynick IM, Rosai J. Follicular Hurthle cell tumors of the thyroid gland. Cancer. 1991;68:1944-1953.
71. Fechner RE, Bentinck BR. Ultrastructure of bronchial oncocytoma. Cancer. 1973;31:1451-1457.
72. Erlandson RA, Reuter VE. Oncocytic adrenal cortical adenoma. Ultrastruct Pathol. 1991;15:539-547.
73. Lloreta J, Vadell C, Fabregat X, Serrano. Fibrolamellar hepatic tumor with neurosecretory features and systemic deposition of AA amyloid. Ultrastruct Pathol. 1994;18:287-292.
74. Tallini G, Ladanyi M, Rosai J, Jhanwar SC. Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors. Cytogenet Cell Genet. 1994;66:253-259.
75. Welter C, Kovacs G, Seitz G, Blin N. Alteration of mitochondrial DNA in human oncocytomas. Genes Chromosomes Cancer. 1989;1:79-82.
76. Hoppeler H, Mathieu-Costello O, Kayar SR. Mitochondria and microvascular design. In: Crystal RG, West JB, eds. The Lung: Scientific Foundations. New York: Raven; 1991:1467-1477.
77. Farkas GA, Roussos C. Adaptability of the hamster diaphragm to exercise and/or emphysema. J Appl Physiol. 1982;53:1263-1272.
78. Macklem PT, Roussos CS. Respiratory muscle fatigue: a cause of respiratory failure?. Clin Sci Mol Med. 1977;53:419-422.
79. Müller-Höcker J. Mitochondria and ageing. Brain Pathol. 1992;2:149-158.
80. Beal MF, Howell N, Bódis-Wollner I, eds. Mitochondria and Free Radicals in Neurodegenerative Diseases. New York: Wiley-Liss; 1997.